Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    Green360 Secures Holcim as First Commercial Eco-Clay Customer in Major Validation Milestone
    • News

  • Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    Aerometrex Expands MetroMap Partner Program as Scalable Model Gains Traction
    • News

  • Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    Middle East Conflict Starts to Hurt Corporate Earnings Outlooks
    • News

  • European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    European Lithium and Critical Metals Secure Control of Tanbreez Rare Earth Project
    • News

  • Harris Technology’s refurbished boom signals FY26 profit inflection
    Harris Technology’s refurbished boom signals FY26 profit inflection
    • News

Wide Open Agriculture Expands Global Footprint with New Sales in Europe, Latin America & Australia

  • In News
  • March 11, 2025
  • Tim Grey
Wide Open Agriculture Expands Global Footprint with New Sales in Europe, Latin America & Australia

Lupin Protein Gains Global Momentum

Wide Open Agriculture (ASX:WOA) is making significant strides in the global plant-based protein market, securing initial commercial sales and purchase orders across five continents. This latest development highlights the growing demand for WOA’s lupin protein isolates, and positions the company as a key player in the alternative protein sector.

“These sales are an important step in proving the commercial viability of our lupin protein,” said Yaxi Zhan, WOA’s Chairperson. “We’ve successfully demonstrated that our products meet the functionality and quality expectations of food manufacturers worldwide.”

New Sales Mark Key Industry Validation

WOA has received purchase orders for over five metric tonnes of its lupin protein isolate, LP90 and Buntine Protein®, from multiple international buyers, including:

  • Tarwi, a European health food company focused on lupin-based products.
  • A Mexican ingredient distributor looking to introduce lupin protein to the Latin American market.
  • A Latin American distributor with operations in Argentina and Chile.
  • An Australian food manufacturer incorporating WOA’s protein into new product formulations.

“These sales reinforce the global potential of our lupin protein and its ability to meet consumer demand for clean, high-performance plant-based ingredients.” Zhan said.

Strategic Focus on High-Value Markets

WOA’s strategy is clear: target premium food and beverage manufacturers while optimising production costs.

“As a company operating with a semi-commercial plant, our goal has always been to validate our protein’s market potential before scaling production. Now, we’ve done just that.” Zhan added.

WOA’s European partner, Tarwi, is preparing to launch a reformulated protein powder featuring WOA’s lupin protein to its 30,000+ Instagram followers.

“We’re thrilled to be working with Wide Open Agriculture,” said Cata Gorgulho, Tarwi’s Managing Director. “Their lupin proteins stood out for their taste, functionality, and quality. We’re confident our consumers will embrace this new formulation.”

Building a Global Supply Chain

WOA’s expansion into Latin America has seen the company enter a region where lupins have been part of traditional diets for centuries.

“Our protein is an excellent fit for these markets, given its neutral flavour and superior performance in food applications such as protein powders, plant-based dairy, and baked goods,” Zhan explained.

These initial orders not only validate the product’s appeal but also strengthen negotiations with distributors and brands in China, North America, the Republic of Korea, and Australia.

Next Steps for WOA

WOA is now focused on:

  • Strengthening partnerships to secure repeat orders.
  • Converting its growing sales pipeline into long-term commercial agreements.
  • Expanding into new markets, particularly China, Korea, and Southeast Asia.

WOA’s ongoing efforts to establish a global network of ingredient buyers position it well for continued growth in the plant-based protein industry.

“With these new orders, we’re not just selling protein—we’re building a global market for lupin as the next big plant-based ingredient,” Zhan concluded.

  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  •  
  •  
  •  
  •  
  • ASX:WOA
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    March 11, 2025, 6:28 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/plant-based-protein

    Reply
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Tim Grey
Latest posts by Tim Grey (see all)
  • AML3D announces stronger FY26, with positive EBITDA reported in the second half - September 1, 2026
  • Imagion Biosystems Advances MagSense® Phase 2 Trial - August 27, 2026
  • Acrux-developed Menopause Hormone Therapy to enter Australian market - May 28, 2026
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.